BKBertil Kågedal

Bertil Kågedal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bertil Kågedal has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Monitoring of Intensive Care Patients by a Physiology-Related GFR Method

    by Bertil Kågedal, Jean-Baptiste Woillard, Stephan Ehrmann, Charlotte Salmon-Gandonnière, Isabelle Benz-De Bretagne, Carl-Fredrik Mandenius

    Background: In the intensive care of critically ill patients, accurate and reliable determination of the glomerular filtration rate (GFR) is of utmost importance. We have previously used one of the most established methods for this purpose, iohexol plasma clearance measurement, in combination with a mechanistic model based on mass balances and physiological intercompartmental transport. Here, we apply this method in an intensive care unit setting to investigate its validity for estimating GFR and to interpret data from critically ill patients. Methods: In 86 patients undergoing advanced supportive care for shock, sepsis, or other severe conditions, GFR was estimated using the clearance of iohexol during 24 h after an intravenous injection. Individual iohexol plasma clearance was determined by the mass balance model. Parameters were fitted to each patient’s plasma clearance profiles to estimate GFR. The model estimates were compared with estimations using the established Bröchner–Mortensen regression approach and a maximum a posteriori Bayesian estimator. Results: Iohexol plasma disappearance was stable over the 24-h monitoring period in 80% of patients, while 20% exhibited unstable elimination profiles. In patients with stable profiles, the mechanistic model showed significant correlations with Bröchner–Mortensen estimates and the Bayesian estimator. Conclusion: This physiology-based model strengthens the determination of GFR by providing interpretable parameters linked to transport and exchange processes between plasma and extracellular volumes and urinary excretion. The model shows that short-term GFR changes can be illustrated during the plasma concentration trajectory of iohexol, and short-term GFRs can be calculated.

  • Open Access

    Use of fomepizole as a novel approach for preventing aciclovir-induced neurotoxicity

    by Åse Östholm, Erik Lindeman, Ylva Böttiger, Dan Eklund, Bertil Kågedal, Marie Studahl, Jan-Olov Höög, Håkan Hanberger, Anders Helldén

  • Open Access

    The sex difference in plasma cystatin C is age-dependent: a systematic review and meta-analysis

    by Filip Landgren, Bertil Kågedal, Eva Landberg

    Cystatin C-based GFR equations (eGFRcys) are inconsistent; some include a sex-adjustment factor while others do not. This reflects ongoing uncertainty about whether cystatin C concentrations differ between sexes in healthy individuals without kidney disease and how any such difference varies with age. We performed a systematic review and meta-analysis to address this discrepancy. We conducted a PRISMA-compliant systematic review (PubMed, Scopus, Embase) of studies reporting sex-specific cystatin C data in healthy adults. From 21 studies comprising more than 46,000 healthy adults, 52 unique subgroups (k = 52) were extracted. Analyses comprised: (1) a meta-regression of all subgroups by mean age; (2) a random-effects model for younger and middle-aged adults (k = 32, age ≤ 60 years); and (3) a separate model for older adults (k = 13, age ≥ 60 years). A qualitative review of pediatric data provided life-course context. The qualitative pediatric review confirmed a consistent 12-15% sex difference (men > women) emerging during adolescence. In younger and middle-aged adults, men had 8.6% higher cystatin C concentrations than women (pooled M/F ratio 1.0860, 95% CI 1.0587-1.1133; p < .0001). In older adults, this difference was markedly attenuated (M/F ratio 1.0338, 95% CI 1.0132-1.0544). Across all adult subgroups, meta-regression indicated an age-related attenuation of the sex difference (β = -0.0011 per year). Between-study heterogeneity was substantial (I² = 98% in younger adults, 76% in older adults), likely reflecting true variability in population characteristics and analytical methods; however, the direction of the sex difference was highly consistent across studies. Sensitivity analyses using robust variance estimation, leave-one-out analysis, and trim-and-fill methods confirmed the robustness of pooled estimates and found no evidence of substantial publication bias. Plasma cystatin C exhibits a consistent, biologically plausible sex difference that varies across the life course, with a pronounced difference in adolescence and early to mid-adulthood that attenuates after 60 years of age. This pattern coincides with age-related changes in sex hormone exposure and, together with experimental and clinical evidence, supports a hormonal contribution to cystatin C regulation. These findings challenge the validity of both sex-neutral eGFRcys equations, which may underestimate kidney function in younger men, and uniform sex-adjustment equations, which may overcorrect in older adults. Our results support the development of age-dependent, sex-specific approaches to cystatin C-based kidney function assessment.

  • Open Access

    Cystatin C and creatinine eGFR reference intervals in healthy adults from Cameroon

    by Bertil Kågedal, Dženeta Nezirević Dernroth, Bertille Elodie Edinga-Melenge, Adrienne Yakam Tchapmi, Jobert Richie Nansseu, Vicky Jocelyne Ama Moor, Suzanne Belinga, Håkan Hanberger, Anders Helldén

    Several equations are available for estimation of glomerular filtration rates (eGFRs) from serum cystatin C and creatinine, but data on reference intervals from healthy subjects are scarce. Employing nine well-known equations, we calculated eGFRs for healthy Cameroonians, 194 men and 187 women 18-71 years of age. Reference intervals were calculated using conventional techniques. For subjects < 50 years of age the eGFR reference intervals were with CAPA (men; women) 70.1-127.1; 79.9-172.2, with CKD-EPIcys 2012 75.1-131.2; 81.3-135.5, with LM rev 65.4-106.5; 61.4-110.3, with CKD-EPIcrea 2021 74.1-127.2; 67.0-129.8, with mean (LM rev, CAPA) 72.2-110.6; 72.8-136.9, with CKD-EPIcrea, cys 2021 81.1-126.6; 77.0-135.7, with EKFCcys 85.5-116.3; 83.3-124.8, with EKFCcrea 69.4-114.2; 62.8-114.3, and with EKFCcrea, cys 82.5-114.0: 77.1-116.4 mL/min/1.73 m2, respectively. Median eGFRcys was significantly higher than eGFRcrea irrespective of equations used. The eGFRcys difference between healthy men and women aged < 50 years may be explained by lower production rates of cystatin C in women. The higher eGFRcys reference intervals compared to that of eGFRcrea may be caused by increased tubular secretion of creatinine or increased production of cystatin C in the cohorts used for establishing the equations relative the case in healthy subjects. This suggests that the eGFR equations need to be further assessed regarding accuracy to adequately correspond to true GFR.


  • Open Access

    Determination of Glomerular Filtration Rate After Contrast-Enhanced CT Among Critically Ill Patients: Support for a New Procedure

    by Bertil Kågedal, Anders Helldén, Dženeta Nezirević Dernroth, Anders Lindgaard Andersen, Andreas MD Ekman, Mats Haglund, Bharti Kataria, Frida Oskarsson, Lovisa Tobieson, Åse Östholm, et al.

    OBJECTIVES: To measure glomerular filtration rate using iohexol plasma clearance (mGFRiohexol) in critically ill patients using the high doses of iohexol administered at CT and to evaluate its agreements with urinary creatinine clearance (uClcr) and estimated glomerular filtration rates (eGFRs), calculated from plasma concentrations of creatinine (eGFRcr) and cystatin C (eGFRcys). DESIGN: Prospective observational cohort study. SETTING: ICUs across Southeast Sweden. PATIENTS: Critically ill adult patients. INTERVENTIONS AND MEASUREMENTS: Twenty-six ICU patients were given high doses of iohexol (range, 27–140 mL) for contrast-enhanced CT, whereafter blood samples were taken in the elimination phase for determination of mGFRiohexol. Plasma iohexol concentrations were determined by high-performance liquid chromatography and mGFRiohexol was calculated. Standard dose (5 mL) of iohexol was administered the following days to compare low-dose clearance results with the high-dose clearance results. Six-hour uClcr was performed four times a day and averaged. MAIN RESULTS: Mean ± sd mGFRiohexol after CT was 77.4 ± 38.1 mL/min (n = 26), and uClcr was 97.3 ± 58.2 mL/min (n = 25) in the critically ill patients. There was a strong positive correlation between mGFRiohexol determined with high and low doses of iohexol in patients with normal or high mGFRiohexol (coefficient of determination [R 2] = 0.88; p < 0.001) and between mGFRiohexol and uClcr (R 2 = 0.87; p < 0.001). eGFRcr overestimated mGFRiohexol and eGFRcys underestimated mGFRiohexol. CONCLUSIONS: mGFRiohexol after contrast-enhanced CT compares well with mGFRiohexol after standard low-dose iohexol respectively uClcr. Over- and underestimation of mGFRiohexol by eGFRcr and eGFRcys is probably explained by increased tubular secretion of creatinine and increased production of cystatin C in intensive care patients.

  • Open Access

    Determination of glomerular filtration rate, a spin off after contrast-enhanced computed tomography among critically ill patients – proof of concept

    by Bertil Kågedal, Anders Helldén, Dženeta Nezirevic Dernroth, Anders Andersen, Andreas Ekman, Mats Haglund, Bharti Kataria, Frida Oskarsson, Lovisa Tobieson, Åse Östholm Balkhed, et al.

    Background: Recently, Gong et al. (Gong et al. 2022) showed, in nine heathy subjects, that plasma clearance of high doses of iohexol given as contrast enhanced computed tomography (CT) could be used for determination of glomerular filtration rate (GFR). We utilized high doses of iohexol from angiographic or other contrast enhanced CT given to critical ill patients for calculation of GFR iohexol and compared these data with standard low dose iohexol GFR determinations. Method: Patients at intensive care units (ICUs) in Southeast Sweden intended for radiographic investigations that included injection of 45-120 ml of iohexol (Omnipaque) were included, and the concentration of iohexol in plasma was measured by HPLC. Iohexol clearance was calculated by the method of Bröchner-Mortensen. The following days was iohexol clearance determined using the standard low dose of 5 mL of iohexol. Sixteen patients admitted to ICUs were included in this pilot study. Results: GFR after high dosing of iohexol at contrast enhanced CT could be measured for all sixteen critically ill patients. Patients with normal or increased renal function had neglectable iohexol concentrations the day following the CT scan. There was excellent correlation between GFR determination with high and standard low iohexol dosing among these 6 patients. Ten patients had decreased renal function and delayed elimination of iohexol, thus was not GFR measurement with low dose iohexol possible to analyse the day after CT scan with high dose iohexol. Conclusion: This pilot study showed that GFR can be measured after high doses of iohexol at enhanced CT and compare well with the standard low dose of iohexol clearance determinations.

  • Open Access

    Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius

    by Marcus Fransson, Anders Helldén, Åse Östholm Balkhed, Dženeta Nezirević Dernroth, Maria Ha, Mats Haglund, Peter Milos, Håkan Hanberger, Bertil Kågedal

    Streptococcus intermedius occasionally causes brain abscesses that can be life-threatening, requiring prompt antibiotic and neurosurgical treatment. The source is often dental, and it may spread to the eye or the brain parenchyma. We report the case of a 34-year-old man with signs of apical periodontitis, endophthalmitis, and multiple brain abscesses caused by Streptococcus intermedius. Initial treatment with meropenem and vancomycin was unsuccessful due to subtherapeutic concentrations, despite recommended dosages. Adequate concentrations could be reached only after increasing the dose of meropenem to 16 g/day and vancomycin to 1.5 g × 4. The patient exhibited high creatinine clearance consistent with augmented renal clearance, although iohexol and cystatin C clearances were normal. Plasma free vancomycin clearance followed that of creatinine. A one-day dose of trimethoprim–sulfamethoxazole led to an increase in serum creatinine and a decrease in both creatinine and urea clearances. These results indicate that increased tubular secretion of the drugs was the cause of suboptimal antibiotic treatment. The patient eventually recovered, but his left eye needed enucleation. Our case illustrates that augmented renal clearance can jeopardize the treatment of serious bacterial infections and that high doses of antibiotics are needed to achieve therapeutic concentrations in such cases. The mechanisms for regulation of kidney tubular transporters of creatinine, urea, vancomycin, and meropenem in critically ill patients are discussed.


  • Pharmacokinetics of 2-Mercaptopropionylglycine (Tiopronin) in Patients with Impaired Renal Function

    by Margaretha S. Carlsson, Torsten Denneberg, Britt-Marie Emanuelsson, Bertil Kågedal, Sune Lindgren


  • Steady-State Pharmacokinetics of 2-Mercaptopropionylglycine (Tiopronin) in Healthy Volunteers and Patients with Cystinuria

    by Margaretha S. Carlsson, Torsten Denneberg, Britt-Marie Emanuelsson, Bertil Kågedal, Sune Lindgren